Maravai LifeSciences Holdings, Inc. reaffirmed financial guidance for the full year 2024. Revenue expectations for 2024 remain in the range of $265.0 million to $285.0 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.96 USD | -0.81% | -2.07% | +65.95% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+65.95% | 1.47B | |
-30.32% | 9.87B | |
-16.78% | 2.75B | |
-15.31% | 2.13B | |
-23.63% | 1.65B | |
+29.75% | 811M | |
-5.02% | 733M | |
-31.53% | 510M | |
+1.59% | 300M | |
-24.93% | 166M |
- Stock Market
- Equities
- MRVI Stock
- News Maravai LifeSciences Holdings, Inc.
- Maravai LifeSciences Holdings, Inc. Reaffirms Financial Guidance for the Full Year 2024